Welcome to our dedicated page for MARZETTI CO SEC filings (Ticker: MZTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MARZETTI CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MARZETTI CO's regulatory disclosures and financial reporting.
Marzetti Co (MZTI) reported a new equity award to one of its directors on a Form 4 filing. On 11/20/2025, the director received 786 restricted stock units, each representing a contingent right to receive one share of Marzetti common stock. The units have an exercise price of $0.0000, meaning no cash payment is required to receive the underlying shares when they become deliverable, and they are listed as directly owned. The award is tied to common stock that becomes exercisable on 11/11/2026, aligning the director’s compensation with future company performance.
Marzetti Co (MZTI) reported a director equity award on a Form 4. A company director received 786 restricted stock units on 11/20/2025. Each restricted stock unit represents a contingent right to receive one share of Marzetti’s common stock.
The derivative securities are shown as held directly, with 786 derivative securities beneficially owned following the transaction. The restricted stock units have an exercisable date and expiration date of 11/11/2026, and the transaction price is reported as $0.0000 per unit.
Marzetti Co (MZTI) reported an insider equity award on a Form 4. A director received 786 restricted stock units on 11/20/2025, each representing a contingent right to receive one share of Marzetti common stock. The derivative security has an exercise price of $0.0000 and is listed with a date exercisable and expiration date of 11/11/2026. Following this transaction, the reporting person is shown as beneficially owning 786 derivative securities directly.
MARZETTI CO (MZTI) reported an insider equity award on a Form 4. A director received 786 restricted stock units (RSUs) on 11/20/2025. Each RSU represents a contingent right to receive one share of the company’s common stock, effectively granting future equity rather than immediate cash.
The RSUs have an exercise price of $0.0000 and are scheduled to become exercisable on 11/11/2026, with the same date listed as the expiration date. Following this award, the filing shows the director beneficially owning 786 derivative securities directly, linking their compensation more closely to the company’s future share performance.
Marzetti Co (MZTI) reported an insider equity award for one of its directors on a Form 4. The filing shows the director acquired 786 restricted stock units on 11/20/2025. Each restricted stock unit represents a contingent right to receive one share of Marzetti’s common stock, effectively tying part of the director’s compensation to the company’s future share price.
After this award, the director beneficially owns 786 derivative securities, held directly. The transaction was reported as an acquisition with a price of $0.0000, reflecting that this was a compensation grant rather than an open-market purchase.
The Marzetti Company reported results from its November 19, 2025 annual shareholder meeting and a higher quarterly dividend. Shareholders elected four directors to terms expiring at the 2028 annual meeting and supported executive pay in a non-binding vote, with 24,572,731 votes in favor. They also approved The Marzetti Company 2025 Omnibus Incentive Plan, which allows a broad range of stock- and cash-based awards, and ratified Deloitte & Touche LLP as auditor for the year ending June 30, 2026. The board raised the regular quarterly cash dividend to $1.00 per common share, payable December 31, 2025 to shareholders of record on December 5, 2025. A total of 26,282,668 common shares were represented at the virtual-only meeting, constituting a quorum.
The Marzetti Company filed a Form S-8 registration statement related to The Marzetti Company 2025 Omnibus Incentive Plan. This filing allows the company to register securities issuable under the plan using a streamlined process designed for employee benefit arrangements.
The company describes how its regulations and Ohio law permit it to indemnify directors and officers when they act in good faith and in a manner they reasonably believe to be in or not opposed to the company’s best interests. It notes existing indemnification agreements and insurance that protect directors and officers in certain situations. The document also includes standard undertakings about updating the registration through future Exchange Act filings and clarifies that certain types of indemnification for liabilities under the Securities Act of 1933 may be limited by public policy.
The Marzetti Company reported first-quarter results for the period ended September 30, 2025. Net sales were $493.5 million, up 5.8% year over year, and diluted EPS was $1.71. Operating income reached $59.3 million with a 24.1% gross margin. Results included $1.1 million of restructuring and impairment charges related to the Milpitas, California facility closure.
Retail net sales rose 3.5% to $247.8 million as New York Bakery frozen garlic bread and licensed brands such as Chick-fil-A sauces, Olive Garden dressings, and Buffalo Wild Wings sauces contributed. Foodservice net sales increased 8.2% to $245.6 million, and operating income grew 43.0% to $34.8 million, aided by cost savings, mix, and pricing. A temporary supply agreement tied to the Atlanta plant added $10.7 million to Foodservice sales.
Cash from operations was $69.5 million, with cash and equivalents at $182.2 million. The company paid cash dividends of $26.3 million ($0.95 per share) and repurchased 6,306 shares. No borrowings were outstanding under the $150 million revolving credit facility. Shares outstanding were approximately 27,486,000 as of October 10, 2025.
The Marzetti Company reported that it issued a press release announcing financial results for the three months ended September 30, 2025. The company furnished the release as Exhibit 99.1 to this Form 8-K.
The common stock of The Marzetti Company trades on the NASDAQ Global Select Market under the symbol MZTI.
Thomas K. Pigott, Vice President, Chief Financial Officer and Assistant Secretary of The Marzetti Company (MZTI), reported insider transactions dated 08/21/2025. The Form 4 shows an acquisition of 2,973 shares (transaction code A) recorded at $0.0000, which increased beneficial ownership to 17,766 shares, followed by a disposition of 887 shares (transaction code F) at $180.29, leaving 16,879 shares beneficially owned after the transactions.
The filing was signed by Patricia S. Callahan as attorney-in-fact on 08/22/2025. All details in this summary are taken directly from the submitted Form 4 and reflect routine officer-level trading and a grant/acquisition event plus a sale.